Department of Clinical Psychology and Psychobiology, Faculty of Psychology, University of Barcelona, Barcelona, Spain.
Department of Medical Oncology, Hospital Universitario Central of Asturias, Oviedo, ISPA, Spain.
Cancer Invest. 2021 Sep;39(8):589-596. doi: 10.1080/07357907.2021.1948561. Epub 2021 Jul 7.
The aim of this study was to compare physicians' and patients' estimates of risk of relapse and toxicity. A prospective, cross-sectional, multicenter study including 735 patients with cancer and 29 oncologists. Physicians' appraisals of risk of relapse with and without chemotherapy (27.5% and 43.1%) and risk of severe toxicity (12.2%) were more realistic than those of patients (34.6%, 78.5%, and 57.4%, respectively). The greater the risk of recurrence and risk of toxicity estimated, the less physicians expressed satisfaction with SDM. Estimations of risk of relapse and toxicity are important in diagnostic and therapeutic decision-making and can help patients face their situation.
本研究旨在比较医生和患者对复发和毒性风险的估计。一项前瞻性、横断面、多中心研究纳入了 735 名癌症患者和 29 名肿瘤学家。与化疗（分别为 27.5%和 43.1%）和严重毒性（12.2%）相关的医生对复发风险和毒性风险的评估比患者（分别为 34.6%、78.5%和 57.4%）更现实。复发风险和毒性风险估计值越高，医生对 SDM 的满意度越低。对复发风险和毒性风险的估计在诊断和治疗决策中很重要，可以帮助患者面对自己的情况。
